Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
Selective serotonin reuptake inhibitors (SSRIs) are a standard of care for the pharmacotherapy of patients suffering from Major Depressive Disorder (MDD). However, only one-half to two-thirds of MDD patients respond to SSRI therapy. Recently, a "multiple omics" research strategy was applie...
Saved in:
Main Authors: | Thanh Thanh L. Nguyen (Author), Duan Liu (Author), Ming-Fen Ho (Author), Arjun P. Athreya (Author), Richard Weinshilboum (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021) -
Suicide attempt with selective serotonin reuptake inhibitor antidepressants
by: Sandra Cuenca Carcelén, et al.
Published: (2021) -
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Orna Diav-Citrin, et al.
Published: (2012) -
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
by: Jeffrey R. Strawn, et al.
Published: (2021) -
Decreased Growth with Serotonin Reuptake Inhibitors
by: J Gordon Millichap
Published: (2002)